Conference Coverage
Conference Coverage
Genomic assay changes minds on HER2+ BC treatment
In a small study, 56% of oncologists revised plans after getting results of HER2DX tests.
Latest News
Teledermatology follow-up after Mohs surgery gets a thumbs up from patients
“A big takeaway from our study is that streamlining this process is really essential for successful implementation,” Laura Rezac, MD, said.
Conference Coverage
ASCO honors Hagop Kantarjian, MD, for leukemia research
Noted Lebanese-American oncologist who leads the leukemia department at MD Anderson Cancer Center is to receive a top award at ASCO 2023.
Latest News
Mohs surgery workforce continues to increase
“If the attrition rate remains stable, even with changes in board certification and potential payor eligibility restrictions, the number of...
Conference Coverage
Atezolizumab is associated with enhanced response in triple-negative breast cancer
The addition of atezolizumab to chemotherapy yielded higher pCR than chemotherapy alone.
Conference Coverage
Metabolic abnormalities boost obesity-related cancer risk
“A significant number of cancer cases could potentially be prevented by targeting the coexistence of metabolic problems and obesity, in particular...
Conference Coverage
Patritumab deruxtecan shows promise for breast cancer patients
Preliminary studies show acceptable safety profiles and clinical responses that justify future trials.
Conference Coverage
T-DXd for HER2-low BC: Analysis confirms adverse effects
But T-DXd demonstrates a manageable safety profile consistent with prior reports, says the author of a new paper.
Conference Coverage
BMI has greater impact on survival in younger breast cancer patients
Study of women on endocrine therapy for breast cancer addresses the effects of BMI on survival.
Latest News
Mohs surgery improves survival in early-stage Merkel cell carcinoma
The findings were from a retrospective cohort study of 2,313 patients diagnosed from 2004 to 2018 with pathologically confirmed negative lymph...
